Christine Chen
banner
christineche.bsky.social
Christine Chen
@christineche.bsky.social
Student Pharmacist with a strong interest in pharmaceutical industry.
Long Non-Coding RNA NEAT1 Inhibits Enterovirus 71 Replication by Enhancing IFN-ß Transcription through DDX60 Signaling: Pathological Insights and Clinical Implications

✅ Just Accepted
🔗 https://bit.ly/49NlxXe
November 15, 2025 at 7:37 PM
Use of Intrathecal Amphotericin for Coccidioidal Meningitis

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3WUFGD9
November 15, 2025 at 7:36 PM
Social precariousness and the outcome of critical illnesses in people living with HIV: a multicenter cohort study

✅ Just Accepted
🔗 https://bit.ly/4nSp4Ha
November 15, 2025 at 7:36 PM
Recalibrating COVID-19 Booster Policy: Lessons From Hybrid Immunity and Global Equity Gaps

✅ Just Accepted
🔗 https://bit.ly/4oVUGMO
November 8, 2025 at 11:37 PM
Covid-19 Associated Mucormycosis: Identifying Mortality Predictors in a Retrospective Cohort Study

✅ Just Accepted
🔗 https://bit.ly/4hTv2Gy
November 8, 2025 at 11:37 PM
Gut microbiota predicts the risk of future COVID-19 hospitalization and mortality: insights from the population-based HELIUS Study

✅ Just Accepted
🔗 https://bit.ly/47Ag2IA
November 8, 2025 at 11:37 PM
Factors influencing antimicrobial choice and duration during the last month of life in hospitalised patients

✅ Just Accepted
🔗 https://bit.ly/47LVRI3
November 8, 2025 at 11:36 PM
Neurosymptomatic CSF escape is a CNS-focused form of ART treatment failure

✅ Just Accepted
#IDSky
🔗 https://bit.ly/47cixSD
November 4, 2025 at 6:20 PM
Impact of discontinuation of contact precautions on healthcare-associated ESBL-producing Escherichia coli in a large tertiary care hospital: an interrupted time-series analysis

✅ Just Accepted
🔗 https://bit.ly/47t7eEk
November 4, 2025 at 6:19 PM
The win ratio should be complemented by other win statistics to provide a comprehensive picture of relative and absolute treatment effects: the case study of the REPRIEVE trial

✅ Just Accepted
🔗 https://bit.ly/4oqSQE6
November 4, 2025 at 6:18 PM
Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration

✅ Just Accepted
#IDSky
🔗 https://bit.ly/42TdG6p
October 23, 2025 at 4:31 PM
Immune responses to BK virus in renal transplant recipients receiving IVIG treatment

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3J9gtBs
October 17, 2025 at 5:49 PM
Metagenomic Sequencing of Blood Culture Broth for Diagnosing Fastidious Endocarditis

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4qbRJcA
October 17, 2025 at 5:49 PM
Approaches to Comparing Influenza Vaccine Effectiveness to Guide Potential Preferential Product Recommendations

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4h5Pi7d
October 11, 2025 at 1:31 AM
Detection of aerosolized Mycobacterium tuberculosis DNA from adults being investigated for pulmonary tuberculosis using an electrostatic sampler in a South African primary care setting

✅ Just Accepted
#IDSky
🔗 https://bit.ly/474fRq0
October 5, 2025 at 1:34 AM
Prognostic value of blood epigenetic biomarkers of aging in persons with well controlled HIV infection

✅ Just Accepted
#IDSky

🔗 https://bit.ly/3IrezvX
October 5, 2025 at 1:34 AM
Partial Oral Therapy for Infective Endocarditis among Adult Infectious Diseases Physicians in the United States: An Emerging Infections Network Survey

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4pOHwCS
September 26, 2025 at 12:14 AM
Metagenomic Next Generation Sequencing and Cardiovascular Infections: Promise and Pitfalls of Polymicrobial Detection

✅ Just Accepted
#IDSky

🔗 https://bit.ly/4pvT4L7
September 26, 2025 at 12:12 AM
Early vs. deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: the START study

✅ Just Accepted
#IDSky
🔗 https://bit.ly/46yCOQU
September 26, 2025 at 12:11 AM
Stated at ACIP: MMRV isn’t acceptable for kids <4 to prevent measles, mumps, rubella & varicella.

❌ False. MMRV/MMR vaccines are safe & highly effective. Studies show only a very small increase in febrile seizure risk after the 1st dose.
September 19, 2025 at 2:47 PM
ACIP members are questioning whether the hepatitis B vaccine should continue to be universally administered to children at birth.

Fact: Implementation of universal birth dose hepatitis B vaccine is the most effective strategy to prevent childhood infections.
September 19, 2025 at 2:46 PM